During the past decade, Medical Research Group of Central Florida conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 40 clinical trials were completed, i.e. on average, 117.6% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 17 clinical trials were completed. i.e. 154.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Research Group of Central Florida" #1 sponsor was "AstraZeneca" with 10 trials, followed by "Sunovion" with 8 trials sponsored, "Pfizer" with 7 trials sponsored, "Shire" with 6 trials sponsored and "Hoffmann-La Roche" with 6 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Research Group of Central Florida" #1 collaborator was "Bristol-Myers Squibb" with 4 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator, "Astra Zeneca, Bristol-Myers Squibb" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Medical Research Group of Central Florida" are "Depressive Disorder, Major" (8 trials), "Schizophrenia" (8 trials), "Alzheimer Disease" (5 trials), "Alzheimer's Disease" (5 trials) and "Type 2 Diabetes" (5 trials). Many other conditions were trialed in "Medical Research Group of Central Florida" in a lesser frequency.

Most popular intervention types in "Medical Research Group of Central Florida" are "Drug" (70 trials), "Other" (7 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (40 trials), "Dapagliflozin" (5 trials), "Metformin" (4 trials), "Rapastinel" (4 trials) and "Lurasidone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Medical Research Group of Central Florida" are 70 trials for "All" genders.

Currently, there are NaN active trials in "Medical Research Group of Central Florida". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 47 completed trials in Medical Research Group of Central Florida, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Research Group of Central Florida, 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".